Ovarian cancer, adrenal gland tumor, endometrial cancer, cervical cancer, breast cancer
Congenital adrenal hyperplasia (17-OH-progesterone> 2.5 ng / mL)
Clinically diagnosed Cushing's disease, acromegaly, gigantism
Type I or II diabetes
Unexplained bleeding from the genital tract
Hormone treatment within the last 2 months

NCT03325023_exc_T1
Condition
Ovarian cancer
NCT03325023_exc_T2
Condition
adrenal gland tumor
NCT03325023_exc_T3
Condition
endometrial cancer
NCT03325023_exc_T4
Condition
cervical cancer
NCT03325023_exc_T5
Condition
breast cancer
NCT03325023_exc_T6
Condition
Congenital adrenal hyperplasia
NCT03325023_exc_T7
Measurement
17-OH-progesterone
NCT03325023_exc_T8
Value
> 2.5 ng / mL
NCT03325023_exc_T9
Scope
17-OH-progesterone> 2.5 ng / mL
NCT03325023_exc_T10
Qualifier
Clinically diagnosed
NCT03325023_exc_T11
Condition
Cushing's disease
NCT03325023_exc_T12
Condition
acromegaly
NCT03325023_exc_T13
Condition
gigantism
NCT03325023_exc_T14
Scope
Cushing's disease, acromegaly, gigantism
NCT03325023_exc_T15
Condition
e I or betes
Un
NCT03325023_exc_T16
Condition
e I diabetes
Un
NCT03325023_exc_T17
Condition
Unexplained bleeding
NCT03325023_exc_T18
Qualifier
genital tract
NCT03325023_exc_T19
Procedure
Hormone treatment
NCT03325023_exc_T20
Drug
Hormone
NCT03325023_exc_T21
Temporal
within the last 2 months